Clinical Trial: Phase 1 Trial in Patients With Human Papillomavirus (HPV)-Associated Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: HPV Associated Cancers
Study Type: INTERVENTIONAL
Official Title: A Phase 1 Trial of TGN-S11 in Patients With Human Papillomavirus (HPV)-Associated Relapsed, Resistant or Metastatic Cancer
Brief Summary:
This is an open-label, non-randomized, Phase I, dose escalation/dose expansion study in cohorts of patients with relapsed, resistant, or metastatic HPV-associated cancers.The Expansion Phase will begin in parallel one dose level lower than the highest dose deemed safe in the Dose Escalation in combination with a PD-1 checkpoint blockade.
Read more